Tarsus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.About TARS
Tarsus Pharmaceuticals, Inc. is a commercial stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis.
CEOBobak Azamian
CEOBobak Azamian
Employees370
Employees370
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2017
Founded2017
Employees370
Employees370
TARS Key Statistics
Market cap2.52B
Market cap2.52B
Price-Earnings ratio-51.76
Price-Earnings ratio-51.76
Dividend yield—
Dividend yield—
Average volume1.25M
Average volume1.25M
High today$59.06
High today$59.06
Low today$57.54
Low today$57.54
Open price$58.71
Open price$58.71
Volume328.46K
Volume328.46K
52 Week high$85.25
52 Week high$85.25
52 Week low$38.51
52 Week low$38.51
Stock Snapshot
With a market cap of 2.52B, Tarsus Pharmaceuticals(TARS) trades at $58.66. The stock has a price-to-earnings ratio of -51.76.
As of 2026-07-25, Tarsus Pharmaceuticals(TARS) stock has fluctuated between $57.54 and $59.06. The current price stands at $58.66, placing the stock +1.9% above today's low and -0.7% off the high.
The Tarsus Pharmaceuticals(TARS)'s current trading volume is 328.46K, compared to an average daily volume of 1.25M.
In the last year, Tarsus Pharmaceuticals(TARS) shares hit a 52-week high of $85.25 and a 52-week low of $38.51.
In the last year, Tarsus Pharmaceuticals(TARS) shares hit a 52-week high of $85.25 and a 52-week low of $38.51.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TARS. This list is generated using Robinhood data, and it’s not a recommendation.